特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
市場調査レポート
商品コード
391477

世界のポジトロン放出断層撮影(PET)市場:成長、動向、予測

Global Positron Emission Tomography (PET) Market - Growth, Trends and Forecasts (2017 - 2022)

出版日: | 発行: Mordor Intelligence LLP | ページ情報: 英文 211 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.49円
世界のポジトロン放出断層撮影(PET)市場:成長、動向、予測
出版日: 2017年01月24日
発行: Mordor Intelligence LLP
ページ情報: 英文 211 Pages
納期: 2-3営業日
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

当レポートでは、世界のポジトロン放出断層撮影(PET)市場について調査し、市場の動向と今後の成長見通し、タイプ別、用途別、地域別動向、および市場に参入する主要企業のプロファイルなどをまとめています。

第1章 イントロダクション

第2章 調査方法

第3章 エグゼクティブサマリー

第4章 主な推論

第5章 市場概要と業界動向

  • 現在の市場シナリオ
  • 市場概要
  • ポーターズファイブフォース

第6章 促進因子、阻害因子、機会、課題分析

  • 市場促進因子
  • 市場阻害因子
  • 市場の機会
  • 主な課題

第7章 市場セグメンテーション

  • タイプ別
    • フルオロン18
    • ルビジウム82
    • その他
  • 用途別
    • 心臓
    • 神経
    • 腫瘍
    • その他

第8章 地域別市場:地域別シェアと予測

  • 北米
  • 欧州
  • アジア太平洋地域
  • 中東・アフリカ
  • ラテンアメリカ

第9章 競合環境

  • 合併・買収
  • 新製品上市
  • 協定、連携、提携

第10章 企業プロファイル

第11章 投資の機会に対するアナリストの見通し

第12章 市場の将来見通し

目次

Description

The global positron emission tomography (PET) market is estimated at USD XX million in 2016 and is projected to reach USD XX million by 2021, growing at a CAGR of XX% during the forecast period.

Positron emission tomography (PET) is a nuclear medicine imaging technique that provides metabolic and functional information. PET technology has reportedly been combined with CT and MRI to provide detailed anatomical and metabolic information. The PET market has gained huge popularity, globally. It is currently exhibiting a highly lucrative growth rate with an increased use of PET, CT, and MRI for diagnosis of cardiac diseases, brain diseases, cancer, etc. Nuclear medicine is being used for therapeutic purposes for treatment of Alzheimer's disease, coronary heart diseases, bone metastasis, and many types of cancer.

Drivers & Restraints

An increasing demand for PET analysis in radiopharmaceuticals, the growing geriatric population, technological advancements in PET imaging for oncology and AD applications, new 99mtc labeled agents for visualizing biologically significant events, and integration of x-ray tomography (CT) into PET are some of the major drivers for the growth of this market. The study of the nuclear medicine diagnostics is emerging rapidly in the form of a promising market. However, shorter half-life of radioisotopes, reimbursement issues, huge capital investment and stringent regulatory guidelines are turning out to be restraints for the market.

Market Segmentation

The positron emission tomography market is segmented by:

Type of Radioisotope

Application

Geography

By type of radioisotope, the market is segmented into Fluorine-18, Rubidium-82 (RB-82), and others. By application, the market is segmented into cardiology, neurology oncology, and others. There is a Cost/Quality Tradeoff trend between the SPECT and PET technologies; PET offers high-resolution images but at a very high cost, whereas SPECT offers low-quality imaging at reasonable costs.

Analyzing the application segment of PET, it is majorly being used in oncology because of good quality of imaging. PET is gradually catching up with SPECT in the cardiology segment. Hence, PET imaging products, which include hybrid PET-CT scanners, expect a potential increase in market size in the coming years.

PET/CT dominates the PET technology market

Geographically, the market is segmented into North America, Europe, Asia-Pacific, the Middle East and Africa and Latin America. North America accounts for the largest market share, followed by Europe and Asia-Pacific. The Asia-Pacific region is expected to grow at the highest CAGR during the forecast period owing to improving research infrastructure in the region, increasing awareness among patients and physicians for radioisotopes, rising incidence of chronic disease like cancer and boost in the population.

During the forecast period, the PET/CT market is expected to grow in the APAC region (excluding Japan) and Rest of the World. PET clearly dominates the market, with a total 5729 procedures in North America and more than 369,636 procedures in the Asia-Pacific.

Continuing improvements in imaging technology for PET have produced greater resolution and shorter imaging times. Promising future advancements like new PET biomarkers for Alzheimer's disease and oncology applications, coupled with increased applications in brain metastases and Parkinson syndromes, are further expected to fuel the growth of this market.

The key players in the market are:

Philips (The Netherlands)

Siemens (Germany)

Positron Corporation (U.S)

Agfa-Gevaert N.V.

CardiArc Ltd.

Digirad Corporation

Gamma Medica Inc.

GE Healthcare

Hologic Inc.

Others

Key Deliverables:

Market analysis for the global positron emission tomography (PET) market, with region specific assessments and competition analysis.

Market definition along with the identification of key drivers, restraints opportunities and challenges.

Identification of factors instrumental in changing the market scenario, rising prospective opportunities, and identification of key companies that can influence this market on a global and regional scale.

Extensively researched competitive landscape section with company profiles of key players with the analysis of their current strategic interests and key financial information.

Identification and analysis of the macro and micro factors that affect the global positron emission tomography (PET) market.

Insights of the market in the regions that have the highest potential for growth and also identify the markets that are still untapped.

Table of Contents

1. INTRODUCTION

  • 1.1 Study deliveratives
  • 1.2 Market Definition
  • 1.3 Sizing Units
  • 1.4 Base Currency
  • 1.5 Review and forecast period years
  • 1.6 General Study Assumptions
  • 1.7 Report Description

2. RESEARCH METHODOLOGY

  • 2.1 Introduction
  • 2.2 Analysis Methodology
  • 2.3 Study timeline
  • 2.4 Study Phases
    • 2.4.1 Secondary Research
    • 2.4.2 Discussion Guide
    • 2.4.3 Market Engineering & Econometric Model
    • 2.4.4 Expert Validation

3. EXECUTIVE SUMMARY

4. KEY INFERENCES

5. MARKET OVERVIEW AND INDUSTRY TRENDS

  • 5.1 Current market scenario
  • 5.2 Market Overview
  • 5.3 Porters Five Force Analysis
    • 5.3.1 Bargaining Power Of Suppliers
    • 5.3.2 Bargaining Power Of Buyers
    • 5.3.3 Degree Of Competition
    • 5.3.4 Threat Of Substitution
    • 5.3.5 Threat Of New Entrants

6. DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES ANALYSIS (DROC)

  • 6.1 Market Drivers
    • 6.1.1 Increasing demand for PET analysis in radiopharmaceuticals
    • 6.1.2 Growing geriatric population
    • 6.1.3 Technological advancements in PET imaging for oncology and AD applications
    • 6.1.4 New 99mTc labeled agents for visualizing biologically significant events
    • 6.1.5 Integration of X-Ray tomography (CT) into PET
  • 6.2 Market Restraints
    • 6.2.1 Shorter half-life of radioisotopes
    • 6.2.2 Reimbursement issues
    • 6.2.3 Huge capital investment
    • 6.2.4 Stringent regulatory guidelines
  • 6.3 Market opportunities
    • 6.3.1 Potential applications in Brain metastases, Parkinsons and AD
    • 6.3.2 Potential radioisotopes in pipeline
    • 6.3.3 Increasing Imaging and Neurological applications
  • 6.4 Key Challenges
    • 6.4.1 Rising fiscal deficit and economic recession

7. Global Positron emission tomography (PET) Market - Segmentation

  • 7.1 BY TYPE OF RADIOISOTOPE
    • 7.1.1 Fluorine-18
    • 7.1.2 Rubidium-82 (RB-82)
    • 7.1.3 Others
  • 7.2 BY APPLICATIONS
    • 7.2.1 Cardiology
    • 7.2.2 Neurology
    • 7.2.3 Oncology
    • 7.2.4 Others

8. Global Positron emission tomography (PET) Market by Geography - Regional shares and forecast

  • 8.1 North America
    • 8.1.1 United States
    • 8.1.2 Canada
    • 8.1.3 Mexico
  • 8.2 Europe
    • 8.2.1 Germany
    • 8.2.2 UK
    • 8.2.3 France
    • 8.2.4 Italy
    • 8.2.5 Spain & Portugal
    • 8.2.6 Scandinavia
    • 8.2.7 Benelux
    • 8.2.8 Rest of Europe
  • 8.3 Asia-Pacific
    • 8.3.1 China
    • 8.3.2 Japan
    • 8.3.3 India
    • 8.3.4 Australia & New Zealand
    • 8.3.5 South Korea
    • 8.3.6 Rest of Asia-Pacific
  • 8.4 Middle East and Africa
    • 8.4.1 GCC
    • 8.4.2 South Africa
    • 8.4.3 Rest of Middle East and Africa
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Argentina
    • 8.5.3 Rest of Latin America

9. Competitive Landscape

  • 9.1 Merger and Acquisition Analysis
  • 9.2 New Product Launches
  • 9.3 Agreements, Collaborations & Partnerships

10. Company Profiles

  • 10.1 Philips (The Netherlands)
  • 10.2 Siemens (Germany)
  • 10.3 Positron Corporation (U.S)
  • 10.4 Agfa Healthcare
  • 10.5 Neusoft Medical Systems
  • 10.6 Gamma Medica Inc.
  • 10.7 GE Healthcare
  • 10.8 Oncovision
  • 10.9 Others

11. Analyst Outlook for Investment Opportunities

12. Future Outlook of the Market

株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.